Simon Irish
First SEC filing: Nov. 4, 2025 · Latest: Nov. 7, 2025
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 28, 2025 | IMSRW | A | 166,298 | · | · | 166,298 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 28, 2025 | IMSRW | Restricted Stock Units | Common Stock | · | · | 166,298 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 20 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 7, 2025 | IMSRW | Common Stock, par value $0.0001 per share ("Common Stock") | 2,295,934 | Direct |
| Nov. 7, 2025 | IMSRW | Common Stock | 2,818,520 | Indirect |
| Nov. 7, 2025 | IMSRW | Common Stock | 52,255 | Indirect |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 24,140 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 107,288 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 178,812 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 2,279,850 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 178,812 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 2,172,563 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 98,347 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 21,905 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 26,286 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 4,381 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 89,406 | Direct |
| Nov. 7, 2025 | IMSRW | Stock Option (Right to Buy) | 178,812 | Direct |
| Nov. 7, 2025 | IMSRW | Restricted Stock Units | 1,023,160 | Direct |
| Nov. 7, 2025 | IMSRW | Warrants (Right to Buy) | 44,703 | Direct |
| Nov. 7, 2025 | IMSRW | Warrants (Right to Buy) | 89,406 | Indirect |
| Nov. 7, 2025 | IMSRW | Contingent Value Right | · | Direct |
| Nov. 7, 2025 | IMSRW | Contingent Value Right | · | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $169,453 | $155,000 | · | · | · | · | · | $13,081,346 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.